| Dec 6, 2025 |
Dec 9, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-7,294
|
-1.69%
|
✗
|
$120.4K |
| Nov 21, 2025 |
Nov 26, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-10,940
|
-2.56%
|
✗
|
$147.2K |
| Nov 17, 2025 |
Nov 19, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-4,466
|
-1.09%
|
✗
|
$64.7K |
| Nov 11, 2025 |
Nov 13, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
48.8
|
-3,328
|
-0.83%
|
✗
|
$38.4K |
| Sep 6, 2025 |
Sep 9, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-7,294
|
-1.81%
|
✗
|
$115.5K |
| Aug 21, 2025 |
Aug 25, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-10,940
|
-2.75%
|
✗
|
$144.7K |
| Aug 17, 2025 |
Aug 19, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-4,409
|
-1.16%
|
✗
|
$58.1K |
| Jul 8, 2025 |
Jul 10, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
97.5
|
+54,521
|
17.30%
|
✗
|
$517.5K |
| Jun 6, 2025 |
Jun 10, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-7,169
|
-2.22%
|
✗
|
$104K |
| May 21, 2025 |
May 23, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-9,999
|
-3.16%
|
✗
|
$118.7K |
| May 17, 2025 |
May 20, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
46.3
|
-3,808
|
-1.28%
|
✗
|
$45.1K |
| Mar 6, 2025 |
Mar 10, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-6,669
|
-2.26%
|
✗
|
$79.8K |
| Feb 17, 2025 |
Feb 19, 2025 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-5,104
|
-1.80%
|
✗
|
$50.1K |
| Dec 6, 2024 |
Dec 9, 2024 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-7,627
|
-2.70%
|
✗
|
$74.4K |
| Nov 17, 2024 |
Nov 19, 2024 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-14,400
|
-5.12%
|
✗
|
$133.3K |
| Sep 6, 2024 |
Sep 10, 2024 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-7,352
|
-2.85%
|
✗
|
$89.6K |
| Aug 17, 2024 |
Aug 21, 2024 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-14,215
|
-5.54%
|
✗
|
$170.8K |
| Jun 6, 2024 |
Jun 10, 2024 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-7,465
|
-3.22%
|
✗
|
$86.1K |
| May 17, 2024 |
May 21, 2024 |
KalVista Pharmaceuticals, Inc.
|
CEO |
Sell |
40.0
|
-21,959
|
-9.21%
|
✗
|
$258.3K |
| Feb 17, 2024 |
Feb 21, 2024 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
40.0
|
-22,802
|
-10.85%
|
✗
|
$321.8K |
| Feb 14, 2024 |
Feb 16, 2024 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
40.0
|
-40,855
|
-20.43%
|
✗
|
$613.2K |
| Nov 17, 2023 |
Nov 21, 2023 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
42.5
|
-13,008
|
-10.37%
|
✗
|
$107K |
| Aug 17, 2023 |
Aug 21, 2023 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
42.5
|
-13,067
|
-12.06%
|
✗
|
$140.2K |
| May 17, 2023 |
May 19, 2023 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
46.3
|
-4,037
|
-4.91%
|
✗
|
$41K |
| Feb 17, 2023 |
Feb 23, 2023 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
46.3
|
-4,954
|
-6.37%
|
✗
|
$37.9K |
| Nov 17, 2022 |
Nov 21, 2022 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
47.5
|
-722
|
-1.04%
|
✗
|
$3.9K |
| Aug 17, 2022 |
Aug 19, 2022 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
46.3
|
-725
|
-1.08%
|
✗
|
$10.8K |
| Feb 23, 2021 |
Feb 25, 2021 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
7.5
|
-29,642
|
-31.32%
|
✓
|
$995.6K |
| Dec 30, 2020 |
Jan 4, 2021 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
50.0
|
-358
|
-1.09%
|
✓
|
$7.2K |
| Apr 18, 2019 |
Apr 22, 2019 |
KalVista Pharmaceuticals, Inc.
|
CFO |
Sell |
22.5
|
-3,073
|
-4.51%
|
✗
|
$79K |